KRISTINE M BALL

CIK 1266163 · See Remarks · last filed 2026-06-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

26

Lifetime Open-Market Net

-$198.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ORKA Director $69.89 $0 2 2026-06-03
Atreca, Inc. (BCEL) Delisted Director $0.15 $0 5 2023-06-15
Forty Seven, Inc. (FTSV) Delisted Director $0 2 2020-04-07
VYNE Therapeutics Inc. (MNLO) Delisted See Remarks 80,300 $0 6 2019-12-16
Relypsa Inc (RLYP) Delisted Chief Financial Officer & SVP 0 -$198.5K 11 2016-09-02

Recent Filings · Page 3 of 3

26 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-09-03 Relypsa Inc (RLYP) Delisted Sell (S) −646 -$14.8K EDGAR
2015-08-19 Relypsa Inc (RLYP) Delisted Sell (S) −710 -$17.6K EDGAR
2015-08-12 Relypsa Inc (RLYP) Delisted Grant (A) +8,250 $0 EDGAR
2015-03-05 Relypsa Inc (RLYP) Delisted Mixed −519 -$131.3K EDGAR
2015-01-23 Relypsa Inc (RLYP) Delisted Mixed -$96.1K EDGAR
2014-08-18 Relypsa Inc (RLYP) Delisted Grant (A) +7,500 $0 EDGAR
Showing 2126 of 26
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.